pharmacie et médicaments – Enjeux autour de l'abaissement du plafond des remises sur les génériques

This written question concerns the potential impact of lowering rebate caps on generic medicines in France. It seeks to understand the implications for the pharmaceutical market and access to affordable treatments. The question addresses stakeholders in the healthcare sector, including pharmaceutical companies, pharmacies, and patients. It aims to clarify policy decisions affecting drug pricing and availability.